Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study.
Saved in:
| Title: | Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study. |
|---|---|
| Authors: | Chappidi MR; Department of Urology, University of Washington, Seattle, Washington., Newcomb LF; Department of Urology, University of Washington, Seattle, Washington.; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zheng Y; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Liu M; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Schenk JM; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zhu K; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., de la Calle CM; Department of Urology, University of Washington, Seattle, Washington.; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Brooks JD; Department of Urology, Stanford University, Stanford, California., Carroll PR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Dash A; Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington., Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.; Department of Urology, Kaiser Permanente, Los Angeles, California., Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Liss MA; Department of Urology, University of Texas Health Sciences Center, San Antonio, Texas., Martin F; Department of Urology, Eastern Virginia Medical School, Virginia Beach, Virginia., McKenney JK; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Morgan TM; Department of Urology, University of Michigan, Ann Arbor, Michigan., Wagner AA; Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Nelson PS; Department of Urology, University of Washington, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Lin DW; Department of Urology, University of Washington, Seattle, Washington.; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington. |
| Source: | The Journal of urology [J Urol] 2025 Sep; Vol. 214 (3), pp. 251-258. Date of Electronic Publication: 2025 Apr 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
